ClinicalTrials.Veeva

Menu

Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years

Children's Hospital of Philadelphia (CHOP) logo

Children's Hospital of Philadelphia (CHOP)

Status

Completed

Conditions

Infant Development

Treatments

Diagnostic Test: Bayley Scales of Infant Development-II
Diagnostic Test: Bayley Scales of Infant Development-III

Study type

Interventional

Funder types

Other

Identifiers

NCT01373177
10-007937

Details and patient eligibility

About

The objective of this randomized study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III (Bayley-III) are higher than scores on the Bayley Scales of Infant Development-II (BSID-II) in the same group of infants who were born very preterm.

Full description

The objective of this randomized crossover study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III are higher than scores on the Bayley Scales of Infant Development-II in the same group of infants who were born very preterm. First, however, the investigators must demonstrate that significant "learning" does not occur when the tests are administered 4-8 weeks apart. The investigators hypothesize that scores on the Bayley-III will be higher than scores on the BSID-II, irrespective of the order in which the tests are administered.

Enrollment

119 patients

Sex

All

Ages

18 to 22 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Birth weight <2000 grams and <32 weeks
  • Corrected age of 18-22 months.

Exclusion criteria

  • English is not the primary language in the child's home.
  • Parent is unable to give informed consent for research participation.
  • Parent is unable to commit to returning for follow-up testing in 4-8 weeks.
  • Infant has severe medical illness or disability expected to impact his/her ability to participate in testing (ex: blindness, deafness, severe cerebral palsy, autism, tracheostomy).
  • No exclusion for economic status, gender, race or ethnicity.
  • Participation in a RCT that restricts timing and administration of developmental testing.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

119 participants in 2 patient groups

BSID-II, then Bayley-III
Active Comparator group
Description:
Receive BSID-II testing 4-8 weeks before Bayley-III testing
Treatment:
Diagnostic Test: Bayley Scales of Infant Development-III
Diagnostic Test: Bayley Scales of Infant Development-II
Bayley-III, then BSID-II
Active Comparator group
Description:
Receive Bayley-III testing 4-8 weeks before BSID-II testing
Treatment:
Diagnostic Test: Bayley Scales of Infant Development-III
Diagnostic Test: Bayley Scales of Infant Development-II

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems